Catalyst Wire Dossier Catalyst Wire Dossier

IMM01-STEM

· Immunis, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IMM01-STEM, covering 2025-10-30 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness [Phase 2]

See pricing